Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Anti-TNF therapy can cause hair loss and skin issues.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Upadacitinib effectively treated severe hair loss in a child.